Thyrotoxicose secondaire à la prise d'amiodarone: intérêts de la thyroïdectomie totale

Dive, Florence;Maiter, Dominique;Mourad, Michel;Le Polain De Waroux, Jean-Benoît;Scavée, Christophe;et.al.
(2017) Louvain médical — Vol. 136, n° 9, p. 516-522 (2017)

Files

2017_Dive_LMed_136_516-522.pdf
  • Restricted Access
  • Adobe PDF
  • 1.31 MB
Request a copy

Details

Authors
Show more
Abstract
(en) [Amiodarone-induced thyrotoxicosis: benefits of total thyroidectomy] Amiodarone, a class III antiarrhythmic agent according to the VaughanWilliams classification, is commonly prescribed to control supraventricular and ventricular arrhythmias, especially in patients with ventricular dysfunction. Amiodarone-induced hyperthyroidism may provoke serious cardiovascular complications, as illustrated by our two clinical cases. The diagnosis of amiodarone-induced thyrotoxicosis may prove tricky at times, and its medical treatment complex. Surgical management of amiodarone-induced hyperthyroidism appears to be an attractive therapeutic option, particularly for patients with a risk of arrhythmias upon amiodarone discontinuation.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Dive, F., Maiter, D., Mourad, M., Le Polain De Waroux, J.-B., Marchandise, S., Barbraud, C., Dano, H., & Scavée, C. (2017). Thyrotoxicose secondaire à la prise d’amiodarone: intérêts de la thyroïdectomie totale. Louvain médical, 136(9), 516-522. https://hdl.handle.net/2078.5/171386 (Original work published 2017)